Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Cognitive Dysfunction × Hormones × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Dementia 1 Cognitive Dysfunction 1 Anomia 1 Alzheimer Disease 1

Interventions

mazdutide 1 Sugars 1 Standard of Care 1 Sodium Chloride 1 Radiotherapy, Intensity-Modulated 1 Memantine 1 Hormones 1 G(M1) Ganglioside 1 Exercise 1 Donepezil 1 Counseling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05894954 2026-02-18

EVANTHEA

Alzheimer's Prevention and Reversal Project, Inc.

Phase 3 Completed

Alzheimer Disease, Anomia, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡